Cellonis Uses Stem Cells to Treat Diabetes

Cellonis Biotechnologies Group, located in Beijing, reported that its autologous stem cells therapy has successfully treated patients with diabetes. The therapy uses stem cells harvested from a patient’s bone marrow. Cellonis claims that, in the best case, the treatment restores a patient’s natural ability to produce insulin and has also reversed complications from diabetes, such as kidney failure. More details...